The identification of inhibitors of nerve growth factor and brain-derived neurotrophic factor
Chronic pain affects up to 43% of the UK population, with 12% reporting moderate to severely limiting chronic pain.1-2 This incidence rate rises with age, with 62% of over 75s being diagnosed.1 The current standard of care for chronic pain almost exclusively involves COX-1, COX-2 or μ-opioid recepto...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Southampton
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.749765 |